Travoprost 0.04 MG/ML Ophthalmic Solution — RxCUI 284008
RxNorm drug concept · Semantic clinical drug
RxCUI 284008
Semantic clinical drug · SCD
● Current RxNorm concept 18 FDA products
29 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI284008
Official nameTravoprost 0.04 MG/ML Ophthalmic Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known astravoprost 0.004 % Ophthalmic Solution; travoprost 40 MCG/ML Ophthalmic Solution
FDA products mapped18
Package NDCs mapped29
Reported Medicaid activity (SDUD)16,632 prescriptions · 35 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Travoprost Ophthalmic: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Travoprost is used to lower the pressure inside your eye — what doctors call intraocular pressure. You might be prescribed it if you have open-angle glaucoma (where the eye's drain...
- What is travoprost eye drops actually used for?
- Evening dosing is intentional — the drop reaches its peak pressure-lowering effect about 12 hours after you use it, so an evening dose gives you the most coverage through the night...
- Why do I have to use it in the evening? Can't I just use it whenever I remember?
🕸️ Concept Web — How Travoprost 0.04 MG/ML Ophthalmic Solution Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Travoprost 0.04 MG/ML Ophthalmic Solution
RxCUI 284008 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Travoprost
283809IN
-
Travoprost
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Travatan
284896BN
-
Travatan
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Travoprost Ophthalmic Solution
374679SCDF -
Travoprost Ophthalmic Product
1162763SCDG -
Travoprost Ophthalmic Solution [Travatan]
363892SBDF -
Travatan Ophthalmic Product
1179204SBDG -
Ophthalmic Solution
7670DF -
Ophthalmic Product
1151135DFG
-
Travoprost Ophthalmic Solution
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Travoprost 0.04 MG/ML
333557SCDC -
Travoprost 0.04 MG/ML Ophthalmic Solution [Travatan]
285032SBD -
Travoprost 0.04 MG/ML [Travatan]
575081SBDC
-
Travoprost 0.04 MG/ML
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Travoprost 0.04 MG/ML
SCDC · 333557 -
Travoprost Ophthalmic Solution
SCDF · 374679 -
Travoprost Ophthalmic Product
SCDG · 1162763
Brand-Name Concepts
-
Travoprost 0.04 MG/ML Ophthalmic Solution [Travatan]
SBD · 285032 -
Travoprost 0.04 MG/ML [Travatan]
SBDC · 575081 -
Travoprost Ophthalmic Solution [Travatan]
SBDF · 363892 -
Travatan Ophthalmic Product
SBDG · 1179204 -
Travatan
BN · 284896
📦 FDA Products & Package NDCs
18 products · 29 package NDCs
29 package NDCs map to RxCUI 284008 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00078-0946-40 | 1 BOTTLE in 1 CARTON (0078-0946-40) / 2.5 mL in 1 BOTTLE | Travatan Z | Novartis Pharmaceuticals Corporation | 2020-09-04 |
| 00378-9651-32 | 1 BOTTLE in 1 CARTON (0378-9651-32) / 2.5 mL in 1 BOTTLE | Travoprost Ophthalmic Solution, 0.004% | Mylan Pharmaceuticals Inc. | 2019-12-18 |
| 00378-9651-50 | 1 BOTTLE in 1 CARTON (0378-9651-50) / 5 mL in 1 BOTTLE | Travoprost Ophthalmic Solution, 0.004% | Mylan Pharmaceuticals Inc. | 2019-12-18 |
| 25021-0002-02 | 1 BOTTLE in 1 CARTON (25021-002-02) / 2.5 mL in 1 BOTTLE | Travoprost Ophthalmic Soluton | Sagent Pharmaceuticals | 2025-07-15 |
| 25021-0002-05 | 1 BOTTLE in 1 CARTON (25021-002-05) / 5 mL in 1 BOTTLE | Travoprost Ophthalmic Soluton | Sagent Pharmaceuticals | 2025-07-15 |
| 42571-0130-21 | 5 BOTTLE in 1 CARTON (42571-130-21) / 5 mL in 1 BOTTLE | Travoprost Ophthalmic | Micro Labs Limited | 2021-04-15 |
| 42571-0130-27 | 2.5 BOTTLE in 1 CARTON (42571-130-27) / 2.5 mL in 1 BOTTLE | Travoprost Ophthalmic | Micro Labs Limited | 2021-04-15 |
| 46708-0625-02 | 1 BOTTLE in 1 CARTON (46708-625-02) / 2.5 mL in 1 BOTTLE | Travoprost ophthalmic solution | Alembic Pharmaceuticals Limited | 2025-12-17 |
| 46708-0625-05 | 1 BOTTLE in 1 CARTON (46708-625-05) / 5 mL in 1 BOTTLE | Travoprost ophthalmic solution | Alembic Pharmaceuticals Limited | 2025-12-17 |
| 51407-0731-05 | 1 BOTTLE in 1 CARTON (51407-731-05) / 5 mL in 1 BOTTLE | Travoprost | Golden State Medical Supply, Inc. | 2022-10-12 |
| 51407-0731-25 | 1 BOTTLE in 1 CARTON (51407-731-25) / 2.5 mL in 1 BOTTLE | Travoprost | Golden State Medical Supply, Inc. | 2022-10-12 |
| 60505-0593-01 | 1 BOTTLE in 1 CARTON (60505-0593-1) / 5 mL in 1 BOTTLE | Travoprost | Apotex Corp. | 2019-12-18 |
| 60505-0593-04 | 1 BOTTLE in 1 CARTON (60505-0593-4) / 2.5 mL in 1 BOTTLE | Travoprost | Apotex Corp. | 2019-12-18 |
| 62332-0510-05 | 1 BOTTLE in 1 CARTON (62332-510-05) / 5 mL in 1 BOTTLE | Travoprost Ophthalmic Solution USP, 0.004% Travoprost | Alembic Pharmaceuticals Inc. | 2019-12-20 |
| 62332-0510-25 | 1 BOTTLE in 1 CARTON (62332-510-25) / 2.5 mL in 1 BOTTLE | Travoprost Ophthalmic Solution USP, 0.004% Travoprost | Alembic Pharmaceuticals Inc. | 2019-12-20 |
| 62332-0625-02 | 1 BOTTLE in 1 CARTON (62332-625-02) / 2.5 mL in 1 BOTTLE | Travoprost ophthalmic solution | Alembic Pharmaceuticals Inc. | 2025-12-17 |
| 62332-0625-05 | 1 BOTTLE in 1 CARTON (62332-625-05) / 5 mL in 1 BOTTLE | Travoprost ophthalmic solution | Alembic Pharmaceuticals Inc. | 2025-12-17 |
| 66758-0095-56 | 1 BOTTLE in 1 CARTON (66758-095-56) / 2.5 mL in 1 BOTTLE | Travatan Z | Sandoz Inc | 2024-09-02 |
| 66758-0095-75 | 1 BOTTLE in 1 CARTON (66758-095-75) / 5 mL in 1 BOTTLE | Travatan Z | Sandoz Inc | 2024-09-02 |
| 68083-0601-01 | 1 BOTTLE in 1 CARTON (68083-601-01) / 2.5 mL in 1 BOTTLE | Travoprost Ophthalmic Solution | Gland Pharma Limited | 2024-07-12 |
| 68083-0602-01 | 1 BOTTLE in 1 CARTON (68083-602-01) / 5 mL in 1 BOTTLE | Travoprost Ophthalmic Solution | Gland Pharma Limited | 2024-07-12 |
| 68462-0943-03 | 1 BOTTLE in 1 CARTON (68462-943-03) / 2.5 mL in 1 BOTTLE | Travoprost Ophthalmic Solution | GLENMARK PHARMACEUTICALS INC | 2024-09-30 |
| 68462-0943-05 | 1 BOTTLE in 1 CARTON (68462-943-05) / 5 mL in 1 BOTTLE | Travoprost Ophthalmic Solution | GLENMARK PHARMACEUTICALS INC | 2024-09-30 |
| 70069-0586-01 | 1 BOTTLE in 1 CARTON (70069-586-01) / 2.5 mL in 1 BOTTLE | Travoprost | Somerset Therapeutics, LLC | 2024-10-10 |
| 70069-0587-01 | 1 BOTTLE in 1 CARTON (70069-587-01) / 5 mL in 1 BOTTLE | Travoprost | Somerset Therapeutics, LLC | 2024-10-10 |
| 71335-2738-01 | 1 BOTTLE in 1 CARTON (71335-2738-1) / 5 mL in 1 BOTTLE | Travoprost Ophthalmic | Bryant Ranch Prepack | 2025-07-28 |
| 71335-2888-01 | 1 BOTTLE in 1 CARTON (71335-2888-1) / 2.5 mL in 1 BOTTLE | Travoprost Ophthalmic | Bryant Ranch Prepack | 2021-04-15 |
| 72162-2432-02 | 1 BOTTLE in 1 CARTON (72162-2432-2) / 2.5 mL in 1 BOTTLE | Travoprost Ophthalmic | Bryant Ranch Prepack | 2024-12-16 |
| 72162-2432-04 | 1 BOTTLE in 1 CARTON (72162-2432-4) / 5 mL in 1 BOTTLE | Travoprost Ophthalmic | Bryant Ranch Prepack | 2024-12-16 |
Observed labelers:
Alembic Pharmaceuticals Inc. (4) ·
Bryant Ranch Prepack (4) ·
Alembic Pharmaceuticals Limited (2) ·
Apotex Corp. (2) ·
Gland Pharma Limited (2) ·
GLENMARK PHARMACEUTICALS INC (2)
· +7 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.